These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20044411)

  • 1. Datapoints: depot antipsychotic use in New York State hospitals, 1994 to 2009.
    Citrome L; Jaffe A; Levine J
    Psychiatr Serv; 2010 Jan; 61(1):9. PubMed ID: 20044411
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipsychotic medication coprescribing in a large state hospital system.
    Jaffe AB; Levine J
    Pharmacoepidemiol Drug Saf; 2003; 12(1):41-8. PubMed ID: 12616846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why change injection sites for depot antipsychotic medication?
    Cox A; Emmerson B; Collyer B; Scott J
    Aust N Z J Psychiatry; 2012 Aug; 46(8):794. PubMed ID: 22495954
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of depot medications in the treatment of schizophrenia.
    Davis JM
    Am J Psychiatry; 2010 Feb; 167(2):125-6. PubMed ID: 20123919
    [No Abstract]   [Full Text] [Related]  

  • 5. [Schizophrenia: prophylaxis prevents recurrence. Low dose depot neuroleptics--an exit from the "revolving door" psychiatry].
    Fortschr Med Suppl; 1993; 147():1-15. PubMed ID: 9260317
    [No Abstract]   [Full Text] [Related]  

  • 6. [Psychopharmocotherapy of schizophrenia in forensic and general psychiatry].
    Stompe T; Schanda H
    Neuropsychiatr; 2011; 25(2):75-84. PubMed ID: 21672506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prescribing practice of psychotropic drugs in a psychiatric university clinic].
    Ambühl B; Würmle O; Michel K
    Psychiatr Prax; 1993 Mar; 20(2):70-3. PubMed ID: 8103601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of inpatient depot antipsychotic prescribing.
    Pabis DJ; Dorson PG; Crismon ML
    Ann Pharmacother; 1996 Dec; 30(12):1381-6. PubMed ID: 8968447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment with new, long-acting antipsychotic drugs without informed consent].
    Skui H; Hellevik V; Hovdal TT; Valle AL
    Tidsskr Nor Laegeforen; 2019 Jan; 139(1):. PubMed ID: 30644678
    [No Abstract]   [Full Text] [Related]  

  • 10. [The significance of depot medication in the long-term-treatment of schizophrenia].
    Kühn KU; Wiedemann K; Hellweg R; Möller HJ
    Fortschr Neurol Psychiatr; 2014 Oct; 82(10):557-65. PubMed ID: 25299626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Depot Neuroleptic Audit Project: identification and implementation of good nursing practice.
    Murray R; Pollock L; Turner G
    J Psychiatr Ment Health Nurs; 1998 Jun; 5(3):221-2. PubMed ID: 9807352
    [No Abstract]   [Full Text] [Related]  

  • 12. A census of out-patients attending for 'depot' medication at a Glasgow Psychiatric Hospital.
    Turner GN
    Health Bull (Edinb); 1984 May; 42(3):141-5. PubMed ID: 6146587
    [No Abstract]   [Full Text] [Related]  

  • 13. Utilization of depot neuroleptic medication in psychiatric inpatients.
    Citrome L; Levine J; Allingham B
    Psychopharmacol Bull; 1996; 32(3):321-6. PubMed ID: 8961774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and effectiveness of depot versus oral antipsychotics in schizophrenia: synthesizing results across different research designs.
    Kirson NY; Weiden PJ; Yermakov S; Huang W; Samuelson T; Offord SJ; Greenberg PE; Wong BJ
    J Clin Psychiatry; 2013 Jun; 74(6):568-75. PubMed ID: 23842008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmaceutical characteristics of depot neuroleptics. Their use and efficacy in the psychiatric clinic].
    Mungiu OC; Chiriţă V; Boişteanu P; Mungiu A; Cosmovici N; Pirozynski T
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):43-7. PubMed ID: 2899341
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of antipsychotics in a medium-long stay psychiatric hospital from 1998 to 2010.
    Lertxundi U; Echaburu SD; Palacios RH
    Int J Psychiatry Clin Pract; 2012 Jun; 16(2):143-7. PubMed ID: 22149967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the CATIE trial on antipsychotic prescribing patterns at a state psychiatric facility.
    Koranek AM; Smith TL; Mican LM; Rascati KL
    Schizophr Res; 2012 May; 137(1-3):137-40. PubMed ID: 22364675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Availability of psychiatric medications to Croatian healthcare users and the influence of availability of atypical antipsychotics on psychiatric hospital morbidity.
    Jukić V; Herceg M; Savić A
    Psychiatr Danub; 2011 Sep; 23(3):320-4. PubMed ID: 21963705
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intervals between hospitalisations in schizophrenia patients under antipsychotics in depot-form versus oral second generation antipsychotics].
    Gutwinski S; Müller P; Koller M
    Psychiatr Prax; 2007 Sep; 34(6):289-91. PubMed ID: 17806015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost analysis of the strategies in the treatment of schizophrenics: the place of sustained release injectable atypical antipsychotics].
    Gasquet I; Bouhassira M; Launois R
    Encephale; 2005; 31(4 Pt 1):517-8. PubMed ID: 16389719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.